Operating Income Summary of NGL Fine-Chem Limited

NGL Fine-Chem Limited's latest annual operating income in 2023 was 416.27 Million INR , up 80.76% from previous year.
NGL Fine-Chem Limited's latest quarterly operating income in 2024 Q1 was 63.45 Million INR , up 145.43% from previous quarter.
NGL Fine-Chem Limited reported an annual operating income of 230.29 Million INR in 2022, down -59.93% from previous year.
NGL Fine-Chem Limited reported an annual operating income of 574.75 Million INR in 2021, down -24.34% from previous year.
NGL Fine-Chem Limited reported a quarterly operating income of 142.98 Million INR for 2023 Q2, up 104.11% from previous quarter.
NGL Fine-Chem Limited reported a quarterly operating income of 416.27 Million INR for 2023 FY, up 80.76% from previous quarter.

Annual Operating Income Chart of NGL Fine-Chem Limited (2023 - 2007)

Historical Annual Operating Income of NGL Fine-Chem Limited (2023 - 2007)

Year	Operating Income	Operating Income Growth
2023	416.27 Million INR	80.76%
2022	230.29 Million INR	-59.93%
2021	574.75 Million INR	-24.34%
2020	759.62 Million INR	461.84%
2019	135.2 Million INR	-54.17%
2018	295 Million INR	73.55%
2017	169.97 Million INR	-24.54%
2016	225.25 Million INR	19.55%
2015	188.41 Million INR	52.42%
2014	123.61 Million INR	43.22%
2013	86.31 Million INR	58.33%
2012	54.51 Million INR	131.84%
2011	23.51 Million INR	-44.93%
2010	42.69 Million INR	3.79%
2009	41.13 Million INR	15.08%
2008	35.74 Million INR	549.98%
2007	5.5 Million INR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	63.45 Million INR	145.43%
2023 Q2	142.98 Million INR	104.11%
2023 FY	416.27 Million INR	80.76%
2023 Q4	129.01 Million INR	18.1%
2023 Q3	109.24 Million INR	-23.6%
2023 Q1	70.05 Million INR	-41.81%
2022 FY	230.29 Million INR	-59.93%
2022 Q1	-21.02 Million INR	-119.1%
2022 Q2	63.74 Million INR	403.22%
2022 Q3	92.7 Million INR	45.42%
2022 Q4	120.37 Million INR	29.85%
2021 Q1	213.88 Million INR	-18.86%
2021 Q4	110.08 Million INR	9.32%
2021 FY	574.75 Million INR	-24.34%
2021 Q3	100.69 Million INR	-32.71%
2021 Q2	149.64 Million INR	-30.03%
2020 Q1	113.5 Million INR	187.28%
2020 Q2	183.51 Million INR	61.68%
2020 FY	759.62 Million INR	461.84%
2020 Q4	263.6 Million INR	29.93%
2020 Q3	202.88 Million INR	10.56%
2019 Q2	23.28 Million INR	-64.61%
2019 FY	135.2 Million INR	-54.17%
2019 Q3	11.65 Million INR	-49.94%
2019 Q1	65.81 Million INR	-51.79%
2019 Q4	39.51 Million INR	238.94%
2018 Q2	53.98 Million INR	51.16%
2018 Q1	35.71 Million INR	-30.64%
2018 Q3	57.5 Million INR	6.54%
2018 Q4	136.5 Million INR	137.36%
2018 FY	295 Million INR	73.55%
2017 Q3	38.95 Million INR	-26.35%
2017 Q1	11.33 Million INR	-79.5%
2017 FY	169.97 Million INR	-24.54%
2017 Q4	51.48 Million INR	32.17%
2017 Q2	52.88 Million INR	366.51%
2016 Q1	62.95 Million INR	7.08%
2016 Q2	45.94 Million INR	-27.02%
2016 FY	225.25 Million INR	19.55%
2016 Q4	55.29 Million INR	-12.71%
2016 Q3	63.35 Million INR	37.88%
2015 FY	188.41 Million INR	52.42%
2015 Q4	58.79 Million INR	38.08%
2015 Q3	42.57 Million INR	-3.26%
2015 Q2	44.01 Million INR	-5.67%
2015 Q1	46.65 Million INR	-0.98%
2014 Q4	47.12 Million INR	493.0%
2014 Q3	7.94 Million INR	-78.68%
2014 Q2	37.26 Million INR	23.47%
2014 Q1	30.18 Million INR	109.63%
2014 FY	123.61 Million INR	43.22%
2013 Q1	28.11 Million INR	68.67%
2013 Q3	14.15 Million INR	-46.43%
2013 Q4	14.39 Million INR	1.75%
2013 FY	86.31 Million INR	58.33%
2013 Q2	26.41 Million INR	-6.03%
2012 Q1	17.7 Million INR	133.01%
2012 Q3	11.82 Million INR	50.62%
2012 Q2	7.85 Million INR	-55.67%
2012 FY	54.51 Million INR	131.84%
2012 Q4	16.66 Million INR	40.95%
2011 FY	23.51 Million INR	-44.93%
2011 Q4	7.59 Million INR	53.27%
2011 Q3	4.95 Million INR	0.0%
2010 FY	42.69 Million INR	3.79%
2009 FY	41.13 Million INR	15.08%
2008 FY	35.74 Million INR	549.98%
2008 Q4	13.57 Million INR	0.0%
2007 FY	5.5 Million INR	0.0%
2007 Q4	5.08 Million INR	0.0%

Peer Operating Income Comparison of NGL Fine-Chem Limited

Name	Operating Income	Operating Income Difference
Abbott India Limited	13.79 Billion INR	96.982%
Cipla Limited	105.7 Billion INR	99.606%
Gland Pharma Limited	16.45 Billion INR	97.47%
GlaxoSmithKline Pharmaceuticals Limited	13.6 Billion INR	96.94%
Kopran Limited	675.44 Million INR	38.371%
Marksans Pharma Limited	7.79 Billion INR	94.657%
Pfizer Limited	9.61 Billion INR	95.669%
Sanofi India Limited	12.19 Billion INR	96.586%
SMS Pharmaceuticals Limited	1.34 Billion INR	68.938%
TTK Healthcare Limited	249.89 Million INR	-66.582%

Global Stocks Search

NGL Fine-Chem Limited (NGLFINE.NS)

Operating Income Summary of NGL Fine-Chem Limited

Annual Operating Income Chart of NGL Fine-Chem Limited (2023 - 2007)

Historical Annual Operating Income of NGL Fine-Chem Limited (2023 - 2007)

Peer Operating Income Comparison of NGL Fine-Chem Limited